- Newt Gingrich
- Dr. Jim Goodnight
- Jim Davis
- Jason Burke
- Melissa A. Fitzpatrick
- Dr. Edward Helton
- Richard B. Ingraham
- Mark Richardson
- Dr. William L. Roper
- Michael H. Samuelson
Keynote Address
 |
Former House Speaker and Founder, Center for Health Transformation
“The 21st Century Intelligent Health System”
When Americans observe the world around them, they recognize the potential to access all the tools and conveniences afforded to them by 21st century advances in technology, communications and transportation. Unfortunately, this is not so in healthcare. We’re still dependent on a structure which has resisted the natural progress and modernization achieved through time by most other surviving American institutions. We can and ought to do better.
Armed with vision and commitment, we can transform our health system into one that provides better outcomes for more people at lower cost and truly leads people to live longer, healthier lives. This system will be knowledge-intense and electronically-based, and structured so that innovation diffusion is rapid, choice is increased and transparency exists in price and quality information.
Using the modern tools that are all around us, we can build a 21st century intelligent health system that saves lives and saves money for all Americans.
Featured Speakers
Dr. Jim Goodnight
CEO,
SAS
Goodnight is CEO of SAS, the world's leading business intelligence software vendor. At the helm since the company's incorporation in 1976, Goodnight has overseen an unbroken chain of revenue growth – a feat almost unheard of in the software industry.
SAS software was originally created by Goodnight and North Carolina State University colleagues to analyze agricultural-research data. Three decades later, it's doing things Goodnight never imagined in his days as a doctoral student in statistics. Today, SAS is best known for sifting massive mountains of data for FORTUNE 500 companies and other organizations most people have heard of. With its unique business model (software licensed annually) and solid reputation for innovation (24 percent of 2005 revenues reinvested in R&D), SAS is among the world's largest privately owned software companies.
Goodnight holds a doctorate in statistics from North Carolina State University, where he was a faculty member from 1972 to 1976. His passion for learning has since led him to endow several NCSU professorships and make education the focus of SAS' philanthropy. Goodnight has also been an active speaker and participant at the World Economic Forum, where business and world leaders discuss such cross-boundary issues such as international standards, regulations and the global economy.
In 2004, Harvard Business School named Jim Goodnight one of the "20th Century's Great American Business Leaders" for his three decades of leading a business that has changed the way Americans have lived, worked and interacted in the 20th century.
Jim Davis
Senior Vice President and Chief Marketing Officer,
SAS
Jim Davis, Senior Vice President and Chief Marketing Officer for SAS, is responsible for providing strategic direction for SAS products, solutions and services, as well as global messaging about SAS.
Upholding the company's focus to be customer-driven, Davis helped lead the transformation of SAS from a tools provider to the customer-centric software solutions provider it is today. He has built a team of strategists with industry-specific expertise who research the marketplace and partner with engineers in R&D to hone customized solutions for each industry. He has overseen a dramatic increase in SAS' profile.
Also known for his industry leadership, Davis has helped develop the Information Evolution Model, a means for companies to assess how effectively they use information to build their business. He co-authored the book Information Revolution: Using the Information Evolution Model to Grow Your Business, which outlines how organizations use and manage information as a corporate asset. The model enables organizations to evaluate their use of information objectively, providing a framework for making improvements necessary to compete in today's global arena.
Jason Burke
Director of Life Sciences Strategy and Solutions, Americas Health and Life Sciences, SAS
Jason Burke is the Director of Industry Strategy and Solutions for the pharmaceutical market segment in SAS’ Americas Health and Life Sciences group. As part of SAS’ commitment to giving life science organizations more insight into their scientific and business operations, Burke consults with industry leaders and executives in pharmaceutical, biotechnology and contract research organizations on emerging business and technology trends. His particular areas of expertise include strategic planning, enterprise architecture and the application of knowledge management and advanced analytical technologies to improving clinical research and development across the broader health and life sciences ecosystem.
Prior to joining SAS, Burke led the development of Microsoft’s “Digital Pharma” industry technology strategy and corresponding architecture. He also served as the head of e-business technology for Quintiles Transnational, where he directed the research, architecture design and overall technology investment in a $100 million strategic development initiative with an online healthcare company. Additionally, Burke served as a business technology leader for Glaxo Wellcome (now GlaxoSmithKline), where he managed a $60 million pharmaceutical business think tank and led the clinical system migration resulting from the merger between Burroughs Wellcome plc and Glaxo plc.
Burke has a Master of Arts in Cognitive Neuroscience from the University of Missouri – Columbia.
Melissa A. Fitzpatrick
RN, MSN, FAAN, Hill-Rom
Melissa Fitzpatrick has held a variety of nursing and healthcare leadership roles including Vice President of Critical Care and Cardiac Services at the Dartmouth-Hitchcock Medical Center and Senior Associate Chief Operating Officer and Chief Nurse Executive at Duke University Medical Center. She also served as the Editor-in-Chief of the Nursing Management Journal and then as the Chief Healthcare Strategist at SAS. Today, Fitzpatrick is Vice President and Chief Clinical Officer for Hill-Rom. In this role, she provides domain expertise, thought leadership and clinical guidance to the teams at Hill-Rom as they work to achieve the vision of enhancing outcomes for patients and those who care for them.
Fitzpatrick earned her BSN at Gwynedd-Mercy College and her MSN at the University of Pennsylvania. She is a nationally and internationally recognized consultant, speaker and author on clinical and leadership issues in healthcare, with many peer-reviewed publications and book chapters to her credit. She is a past President of the American Association of Critical-Care Nurses and the Foundation for Critical Care. Fitzpatrick was inducted as a fellow in the American Academy of Nursing in 1997 and was selected as a Great 100 nurse in North Carolina in 2002. She lives in Chapel Hill, NC, with her husband, Tom, and their two sons, Brian and Jordan.
Dr. Edward Helton
Chief Scientist, Regulatory and Biomedical Affairs, SAS
Dr. Edward Helton is the Chief Scientist at SAS in Regulatory and Biomedical Affairs and works primarily in the development of Part 11-compliant software (SDD) and serves as a SAS interface to the pharmaceutical and healthcare industries. He has worked in the pharmaceutical industry, academia (University of Virginia and Albany Medical schools and New Mexico State University), at the Federal Drug Administration (Career Research Safety Scientist), and in healthcare in drug safety and efficacy. He also served as a Captain in the US Army Medical Service Corps.
Helton has a BA in chemistry from Texas Tech University, an MA in biology from the College of William and Mary and a PhD in biology (endocrine hormones pharmacokinetics and metabolism) from the University of California, Santa Barbara. He was a National Institutes of Health Fellow and World Health Organization Postdoctoral Scientist in steroid biochemistry. A member of the Endocrine Society, Society of Toxicology, American Association for Clinical Chemistry and the American Chemical Society, Helton is also on the Clinical Data Interchange Standards Consortium board of directors and the Co-Chair of the Health Level Seven Regulated Clinical Research Information Management Technical Committee and Outreach Committee for Clinical Research (ex officio HL7 BOD).
He has approximately 55 peer-reviewed publications.
Richard B. Ingraham
Global Marketing Manager, Healthcare Benefit Plans, SAS
Richard Ingraham brings a unique understanding of the shared business and delivery issues, along with conflicting incentive structures, within the healthcare provider, payer and IT analytic industries. Ingraham has served in various executive capacities across both private and public entities within each of these three key driver industries of healthcare improvement.
Since joining SAS in 1998, Ingraham’s efforts have been directed toward working with senior-level management teams in the healthcare sector in their efforts to improve strategic decision making processes, knowledge management and the alignment of information technology capacities with business. In 2002, Ingraham dedicated his efforts to provide industry knowledge for SAS’ Health and Life Sciences Division, focusing on the health payer sector. He now serves as the Global Marketing Manager for the Health Benefit Plan Industry and has identified improving analytics for the shift to electronic medical records, the disease management process, detection and prevention of fraudulent claims, provider performance reporting and profiling, consumer-driven health plan analytics, and customer profitability intelligence as key SAS focus areas for this sector.
Prior to working with SAS, Ingraham was the Director of Case Management for Equicor (HCA and Equitable joint venture), VP Operations for CIGNA, and Controller and Chief Financial Officer for the Health Services Group. Ingraham has directed numerous managed care program design and development initiatives as well as strategic acquisition projects. His knowledge of claims patterns and analysis for fraud detection was formed both via his DOI and Equicor posts. He presents expertise in risk stratification for disease and medical case management, medical utilization improvements, provider performance and quality benchmarking, process engineering, and internal control projects within the health insurance arena.
At each stage of his career, Ingraham has been engaged in efforts to improve the method of information sharing and collaboration across the healthcare payer and provider sectors.
Mark Richardson
Senior Executive, Health & Life Sciences Company, Accenture
Mark Richardson is a Senior Executive in Accenture's Health & Life Sciences organization where he serves as a leader in the Information Management Capability group, with a primary focus on health insurance clients. Richardson typically serves as a project delivery executive and subject matter specialist for a variety of client projects, including complex information management and business intelligence solutions, custom Internet applications, and IT performance strategy and benchmarking projects. He is also a leader in Accenture's ongoing health insurance benchmarking studies and has worked in the consulting industry for more than 23 years.
 |
Dr. William L. Roper
Dean, UNC School of Medicine, and CEO, UNC Health Care System
William L. Roper is Dean of the UNC School of Medicine and CEO of the UNC Health Care System. He is also Professor of Pediatrics in the School of Medicine at UNC and Professor of Health Policy and Administration in the School of Public Health. From 1997 until March 2004, he was UNC’s Dean of the School of Public Health.
Before joining UNC in 1997, Roper was Senior Vice President of Prudential HealthCare. He joined Prudential in 1993 as President of the Prudential Center for Health Care Research.
Before coming to Prudential, Roper was Director of the Centers for Disease Control and Prevention (CDC), served on the Senior White House Staff and was Administrator of the Health Care Financing Administration (responsible for Medicare and Medicaid). Earlier, he was a White House Fellow.
He received his MD from the University of Alabama School of Medicine and his MPH from the University of Alabama at Birmingham School of Public Health. He completed his residency in pediatrics at the University of Colorado Medical Center.
Roper is a member of the Institute of Medicine of the National Academy of Sciences. He is a member of the board of trustees of the Robert Wood Johnson Foundation, a member of the board of directors of DaVita Inc., a member of the board of directors of Delhaize Group, a member of the board of directors of the UNC Health Care System, a member of the President’s Commission on White House Fellowships and Chairman of the board of directors of the National Quality Forum.
He lives with his wife, Dr. Maryann Roper, a pediatric oncologist, and their son, Will, in Chapel Hill, NC.
 |
Michael H. Samuelson
President and CEO, The Health & Wellness Institute
Michael H. Samuelson currently serves as the President and CEO of The Health & Wellness Institute, a subsidiary of Blue Cross and Blue Shield of Rhode Island. Previously, Samuelson was the President and CEO of The National Center for Health Promotion (NCHP), a health and productivity consulting organization he co-founded in 1977. Over the years NCHP earned a reputation as an international leader in the design and delivery of disease management, training, leadership and health promotion systems. As President and CEO, Samuelson led his marketing team in providing services to over 1,000 corporations and 800 medical centers. Samuelson is widely published and is a director, consultant and advisor to numerous prestigious boards and organizations including The Men’s Health Network, The HERO Forum for Optimal Employee Health and The Lance Armstrong Foundation. His work in the area of behavior change, health economics and healthcare consumer advocacy has been featured on 20/20, The CBS Morning Show, CNN and MSNBC. Samuelson serves on a number of national cancer boards and, at the request of former President George H. W. Bush, is a member of C-Change – an assembly of the nation's key cancer leaders from government, business and nonprofit sectors.
Sponsor:
 |